Transplant Genomics Inc.
Biotechnology company · Mansfield, Massachusetts, United States
Transplant Genomics Inc. is a biotechnology company headquartered in Mansfield, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $8 million sold in a notice filed in 2018.
Transplant Genomics at a glance
What does Transplant Genomics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $8 million sold (2018).
Frequently asked questions about Transplant Genomics
Where is Transplant Genomics headquartered?
Transplant Genomics Inc. is headquartered in Mansfield, Massachusetts, United States.
What does Transplant Genomics do?
Transplant Genomics Inc. is a biotechnology company.
When was Transplant Genomics founded?
The earliest incorporation on record for Transplant Genomics Inc. is in 2013, according to public company registers.
Similar companies
- VeraMorph Inc.Mansfield, Massachusetts, United States
- Phagepro, Inc.Mansfield, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences